Indian Pharmacopoeia Commission

Indian Pharmacopoeia Commission The Indian Pharmacopoeia Commission (IPC) is an autonomous institution under the Ministry of Health and Family Welfare, GoI.

It sets standards for drugs, ensuring their quality, safety, and efficacy to promote public health in India and beyond. The Indian Pharmacopoeia Commission (IPC) is an autonomous institution under the Ministry of Health and Family Welfare, Government of India. It sets standards for drugs in the country, ensuring their quality, safety, and efficacy to promote public health in India and beyond. IPC

regularly updates these standards in the Indian Pharmacopoeia (IP), the official book of drug standards in India, and establishes IP Reference Standards (IPRS) and impurities for quality control analysis. It also updates the National Formulary of India (NFI) to guide healthcare professionals on rational medication practices. Additionally, IPC oversees the Pharmacovigilance Programme of India (PvPI) for drug safety monitoring and the Materiovigilance Programme of India (MvPI) for medical device safety.

Application are invited for In-Person for the Brainstorming Session on “Building a Comprehensive Ecosystem for Patient S...
12/06/2026

Application are invited for In-Person for the Brainstorming Session on “Building a Comprehensive Ecosystem for Patient Safety: Ensuring Quality of Medicines, Medical Devices and Blood Products in India”, scheduled to be held on July 07, 2026, at Yashoda Medicity, Indirapuram, Ghaziabad.

The details of the session are as follows:
Registration Fee: NIL
Mode: In-person (Physical only)
Registration Link: https://docs.google.com/forms/d/e/1FAIpQLSdzTQfhHlj4LBnd1TA0--Oz2J85EE3mNJuy6_UUz5IXJGd1tg/viewform?usp=publish-editor
Last Date of Application: 30 June 2026
Venue: Yashoda Medicity, Indirapuram, Ghaziabad

Scientific Conclave on Indian Pharmacopoeia (IP) 2026 Held in HaridwarIPC organized a Scientific Conclave and Interactiv...
11/06/2026

Scientific Conclave on Indian Pharmacopoeia (IP) 2026 Held in Haridwar

IPC organized a Scientific Conclave and Interactive Session on Indian Pharmacopoeia (IP) 2026 “Strengthening Pharmaceutical Manufacturing through Pharmacopoeial Standards and Quality Compliance” at Haridwar yesterday, in collaboration with the Association of Devbhumi Pharma Industries (ADPI) and affiliated pharmaceutical manufacturing associations of Uttarakhand.

The conclave was organized with the objective of enhancing awareness on the provisions of IP 2026 and promoting quality compliance across the pharmaceutical manufacturing sector.

The programme brought together representatives from pharmaceutical manufacturing units, quality control and quality assurance professionals, regulatory authorities, analytical scientists, and drug testing laboratory personnel to deliberate on recent developments in pharmacopoeial standards and their implementation in the pharmaceutical industry.

Registration deadline extended to 20th June 2026.IPC Announces Conference on “Ensuring Quality of Blood and Blood Compon...
11/06/2026

Registration deadline extended to 20th June 2026.

IPC Announces Conference on “Ensuring Quality of Blood and Blood Components through IP 2026”

Indian Pharmacopoeia Commission (IPC), Ghaziabad, invites registrations for a focused conference on the implementation of IP 2026 standards for Blood and Blood Components, aimed at enhancing quality, regulatory compliance, and patient safety across blood centres.

Date: June 24, 2026 (Wednesday)
Time: 10:00 AM – 05:00 PM IST
Venue: Padma Shri Dr. Nitya Anand Auditorium, IPC, Ghaziabad
Who should attend: Blood centre professionals, QA/QC personnel, regulatory officers, laboratory staff, healthcare administrators, and government health officials.

Registration Fee: ₹590/- (Inclusive of 18% GST)
Last date for registration: June 20, 2026
Seats are limited — first-come, first-served.

Scan the QR code in the event flyer to register.

A walk-in interview is going to be held on 16th June 2026 for filling the vacant positions at the Indian Pharmacopoeia C...
09/06/2026

A walk-in interview is going to be held on 16th June 2026 for filling the vacant positions at the Indian Pharmacopoeia Commission (IPC), an Autonomous organization under the Ministry of Health & Family Welfare, Ghaziabad, through an Outsourcing Manpower Providing Agency.

Another Milestone for the Indian Pharmacopoeia (IP)! Strengthening international collaboration in medicine quality stand...
04/06/2026

Another Milestone for the Indian Pharmacopoeia (IP)!

Strengthening international collaboration in medicine quality standards, the Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding (MoU) with the Food and Drug Department and the Ministry of Health, Lao PDR, for the recognition of the Indian Pharmacopoeia.

The agreement was formally exchanged during the 10th India–Lao PDR Joint Commission Meeting, co-chaired by External Affairs Minister Dr. S. Jaishankar, reflecting the shared commitment of both nations to align medicinal standards and enhance healthcare collaboration.

With this development, the Indian Pharmacopoeia is now recognized by 24 countries, marking another milestone in India's journey towards global leadership in medicine quality standards.

The growing international acceptance of IP highlights the trust placed in India's scientific, regulatory, and quality assurance frameworks and reinforces its role in promoting safe, effective, and quality-assured medicines worldwide.

Registrations Now Open! Join the National Capacity Building Programme on Materiovigilance System in India and contribute...
04/06/2026

Registrations Now Open!

Join the National Capacity Building Programme on Materiovigilance System in India and contribute to strengthening medical device safety and patient care.

Organized by NIMHANS, Bengaluru and Shri Atal Bihari Vajpayee Medical College & Research Institute, Bengaluru, in collaboration with the Indian Pharmacopoeia Commission (IPC) under the Materiovigilance Programme of India (MvPI), this programme aims to enhance awareness and build capacity in medical device safety and vigilance.

Who Should Attend?
Healthcare Professionals
Biomedical Engineers
Researchers & Academicians
Industry Stakeholders
Students

Date: 10 July, 2026 (Friday)
Venue: Platinum Jubilee Hall, NIMHANS, Bengaluru
Theme: Safeguarding Patients through Robust Medical Device Safety and Vigilance Systems
Registration Deadline: 30 June 2026

Be a part of meaningful discussions on adverse event reporting, regulatory perspectives, digital reporting tools, case studies, and future directions in materiovigilance.

Register today and join the movement towards safer medical devices and improved patient outcomes.

Link to apply: https://docs.google.com/forms/d/e/1FAIpQLSfN053UUn7x6FLTz0c6kzA98F0s0J-S4MlBVdvqtVO5KxsQVA/viewform

New publication alert | Pregabalin misuseThe Indian Pharmacopoeia Commission (IPC) is proud to share that the article ti...
02/06/2026

New publication alert | Pregabalin misuse

The Indian Pharmacopoeia Commission (IPC) is proud to share that the article titled "Patterns of pregabalin misuse: Need for intervention" has been published in the Indian Journal of Medical Research (IJMR).

Pregabalin is widely prescribed for epilepsy, neuropathic pain, and anxiety disorders. However, increasing misuse for recreational purposes has emerged as a growing public health concern in India.

Key highlights:

Comprehensive assessment of pregabalin misuse using global pharmacovigilance data.

• Rising misuse trends in India, especially among adult males aged 18–44 years
• Majority of reported Indian cases were serious and required medical intervention
• Highlights the urgent need for stricter regulation and targeted public health interventions

Read the full article

Indian J Med Res. 2026;163(5):647–652 · DOI: 10.25259/IJMR_2462_2025

ijmr.org.in/patterns-of-pregabalin-misuse-need-for-intervention/

Congratulations to Tanushree Sarvepalli, Sandeep Mewada, Dr. Shatrunajay Shukla, and Dr. Vivekanandan Kalaiselvan on this scientific contribution towards strengthening drug/device safety and Pharmacovigilance/Materiovigilance in India.

Grateful to all the contributors for supporting this important safety research. Together, let us continue promoting safer healthcare systems and evidence-based regulatory practices.

IPC Announces Conference on “Ensuring Quality of Blood and Blood Components through IP 2026”Indian Pharmacopoeia Commiss...
29/05/2026

IPC Announces Conference on “Ensuring Quality of Blood and Blood Components through IP 2026”

Indian Pharmacopoeia Commission (IPC), Ghaziabad, invites registrations for a focused conference on the implementation of IP 2026 standards for Blood and Blood Components, aimed at enhancing quality, regulatory compliance, and patient safety across blood centres.

Date: June 24, 2026 (Wednesday)
Time: 10:00 AM – 05:00 PM IST
Venue: Padma Shri Dr. Nitya Anand Auditorium, IPC, Ghaziabad

Who should attend: Blood centre professionals, QA/QC personnel, regulatory officers, laboratory staff, healthcare administrators, and government health officials.

Registration Fee: ₹590/- (Inclusive of 18% GST)
Last date for registration: June 11, 2026

Seats are limited — first-come, first-served.

Scan the QR code in the event flyer to register.

Applications Open – MvPI Internship Programme 2026!Are you passionate about healthcare, patient safety, and medical devi...
29/05/2026

Applications Open – MvPI Internship Programme 2026!

Are you passionate about healthcare, patient safety, and medical devices?
The Materiovigilance Programme of India (MvPI) invites students from healthcare and life-science backgrounds to apply for its internship programme.
Open for students of: Pharmacy, biomedical engineering, nursing, public health, biotechnology, microbiology, or clinical research.

This internship gives you:-
🔹 Real-time exposure to medical device safety monitoring
🔹 Hands-on learning in reporting and data evaluation
🔹 Experience within a national healthcare programme
🔹 Opportunities to build research and analytical skills
Join the mission to strengthen safer healthcare practices across India.
Apply Here: https://forms.gle/PryBmcDcbKBv1zyn9

We are delighted to share the successful completion of the National Conclave cm Workshop on Medication Safety–Patient S...
23/05/2026

We are delighted to share the successful completion of the National Conclave cm Workshop on Medication Safety–Patient Safety: “Navigating Special Scenarios & Antimicrobial Resistance” held at AIIMS Kalyani organized by the Department of Pharmacology, AIIMS Kalyani, in collaboration with Indian Pharmacopoeia Commission.

The conclave brought together industry experts, healthcare professionals, academicians, and researchers for extensive deliberations and training on patient safety, medication safety, and the multisectoral goals of the Pharmacovigilance Programme of India.

The programme featured insightful deliberations on the significance of pharmacovigilance in the Indian scenario, rational use of medicines, industry and academic perspectives, pharmacovigilance in clinical trials, and medication safety in special populations with comorbid conditions. Sessions on community pharmacology initiatives, along with discussions on the importance and key features of the Indian Pharmacopoeia, further enriched the learning experience for participants.

The conclave was conducted under the esteemed patronage of Prof. Dr. YK Gupta Gupta, President, AIIMS Kalyani. Eminent experts including Dr. Jai Prakash, Prof. (Dr.) Bikash Medhi, Prof. (Dr.) Arvind Sinha, Prof. (Dr.) Madhabananda Kar, and Dr. Suparna Chatterjee delivered valuable insights on patient safety and medication safety. Prof. (Dr.) Tirthankar Deb served as the Organizing Secretary of the conclave.

The event successfully fostered meaningful panel discussions, knowledge sharing, and collaborative learning on key aspects of pharmacovigilance, further strengthening the commitment towards safer healthcare practices and pharmacovigilance excellence in India.

Kalaiselvan Vivekanandan Aiims,kalyani

Address

Indian Pharmacopoeia Commission
Ghaziabad
201002

Opening Hours

Monday 9:30am - 5:30pm
Tuesday 9:30am - 5:30pm
Wednesday 9:30am - 5:30pm
Thursday 9:30am - 5:30pm
Friday 9:30am - 5:30pm

Telephone

+919654631395

Website

Alerts

Be the first to know and let us send you an email when Indian Pharmacopoeia Commission posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Indian Pharmacopoeia Commission:

Shortcuts

Share

Category